Aortic Center, Marie Lannelongue Hospital, Le Plessis-Robinson, Paris Saclay University, Paris, France.
German Aortic Center Hamburg, Department of Vascular Medicine, University Heart and Vascular Center, Hamburg, Germany.
J Vasc Surg. 2023 Jun;77(6):1806-1814.e2. doi: 10.1016/j.jvs.2022.11.037. Epub 2022 Nov 12.
A proximal seal extension, after previously failed standard endovascular abdominal aortic aneurysm repair (EVAR), has been described using various endovascular techniques. The aim of the present systematic review was to assess the technical success, 30-day mortality, and mortality and reintervention rates during the available follow-up for patients managed with endovascular methods after failed endovascular repair.
The present systematic review followed the PRISMA (preferred reporting items for systematic reviews and meta-analyses) statement and was preregistered at PROSPERO (no. CRD42022350436). A search of the English literature, via Ovid, using the MEDLINE, EMBASE, and CENTRAL databases, until June 15, 2022, was performed. Observational studies (2000-2022) and case series with at least five patients who had undergone fenestrated/branched EVAR (F/BEVAR) after failed EVAR were considered eligible. Technical success and mortality at 30 days and the mortality and reintervention rates during available follow-up had to have been reported. The Newcastle-Ottawa scale was used to assess the risk of bias. The primary outcome was technical success and mortality at 30 days.
The initial search yielded 2558 reports. Ten studies were considered eligible, two of which were prospective. A total of 423 patients had undergone F/BEVAR after failed EVAR. The indication for reintervention was the presence of a type Ia endoleak in 44.9%. Technical success was reported in seven studies, and 319 of 336 interventions were considered successful (94.9%), according to each study's criteria. Of the 423 patients, 10 had died within 30 days (2.4%). Seven patients had presented with spinal cord ischemia (2.4%). Twenty-three acute kidney injury events were reported (6.8%). The mean follow-up was 18 months (range, 1-77 months). During follow-up, 47 deaths were reported (14.8%). Finally, 50 reinterventions of 303 procedures (16.5%) had been performed.
According to the available literature, F/BEVAR after failed EVAR can be performed with high technical success and low mortality during the perioperative period. The midterm mortality and reintervention rates were acceptable. However, further data are needed to provide firm conclusions regarding the safety and durability of F/BEVAR after failed EVAR.
在先前标准的血管内腹主动脉瘤修复(EVAR)失败后,已经描述了使用各种血管内技术进行近端密封延伸。本系统评价的目的是评估技术成功率、30 天死亡率以及在有随访期间的死亡率和再介入率,这些患者通过血管内方法进行管理,这些方法是在血管内修复失败后使用的。
本系统评价遵循 PRISMA(系统评价和荟萃分析的首选报告项目)声明,并在 PROSPERO(编号 CRD42022350436)上进行了预先注册。通过 Ovid 对英语文献进行了搜索,使用了 MEDLINE、EMBASE 和 CENTRAL 数据库,截至 2022 年 6 月 15 日。观察性研究(2000-2022 年)和至少有 5 例患者接受过血管内开窗/分支 EVAR(F/BEVAR)的病例系列研究被认为符合条件。必须报告 30 天的技术成功率和死亡率以及可用随访期间的死亡率和再介入率。纽卡斯尔-渥太华量表用于评估偏倚风险。主要结局是 30 天的技术成功率和死亡率。
最初的搜索产生了 2558 份报告。有 10 项研究被认为符合条件,其中 2 项为前瞻性研究。共有 423 例患者在 EVAR 失败后接受了 F/BEVAR。再介入的指征是存在 I 型内漏,占 44.9%。根据每项研究的标准,有 7 项研究报告了技术成功率,336 项干预中有 319 项(94.9%)被认为是成功的。在 423 例患者中,有 10 例在 30 天内死亡(2.4%)。有 7 例出现脊髓缺血(2.4%)。报告了 23 例急性肾损伤事件(6.8%)。平均随访时间为 18 个月(范围,1-77 个月)。在随访期间,报告了 47 例死亡(14.8%)。最后,进行了 303 例中有 50 例(16.5%)的再介入。
根据现有文献,EVAR 失败后进行 F/BEVAR 可以获得较高的技术成功率和围手术期低死亡率。中期死亡率和再介入率是可以接受的。然而,需要进一步的数据来提供关于 EVAR 失败后 F/BEVAR 的安全性和耐久性的可靠结论。